Rice Hall James & Associates, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Rice Hall James & Associates, LLC

$1.63 Billion
Q1 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 618,798 shares of KNSA stock, worth $11.6 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

618,798

Previous 636,029 2.71%

Holding current value

$11.6 Million

Previous $11.2 Million 9.44%

% of portfolio

0.75%

Previous 0.67%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$17.63 - $21.74 $303,782 - $374,601	-17,231 Reduced 2.71%	618,798 $12.2 Million
Q4 2023 Feb 08, 2024	SELL	$14.37 - $19.07 $206,022 - $273,406	-14,337 Reduced 2.2%	636,029 $11.2 Million
Q3 2023 Nov 02, 2023	SELL	$13.62 - $20.2 $132,903 - $197,111	-9,758 Reduced 1.48%	650,366 $11.3 Million
Q2 2023 Jul 24, 2023	BUY	$10.44 - $16.48 $46,645 - $73,632	4,468 Added 0.68%	660,124 $9.29 Million
Q1 2023 May 11, 2023	SELL	$10.7 - $15.79 $444,114 - $655,379	-41,506 Reduced 5.95%	655,656 $7.05 Million

Q4 2022 Jan 27, 2023	SELL	$11.42 - $17.05 $602,644 - $899,745	-52,771 Reduced 7.04%	697,162 $0
Q3 2022 Nov 01, 2022	SELL	$9.76 - $13.41 $631,862 - $868,163	-64,740 Reduced 7.95%	749,933 $9.63 Million
Q2 2022 Aug 08, 2022	BUY	$7.6 - $11.41 $20,907 - $31,388	2,751 Added 0.34%	814,673 $7.89 Million
Q1 2022 May 05, 2022	BUY	$9.3 - $12.37 $921,769 - $1.23 Million	99,115 Added 13.9%	811,922 $8.07 Million
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $255,251 - $372,190	-24,567 Reduced 3.33%	712,807 $8.39 Million
Q3 2021 Nov 09, 2021	BUY	$11.39 - $16.23 $34,261 - $48,819	3,008 Added 0.41%	737,374 $8.4 Million
Q2 2021 Jul 29, 2021	BUY	$13.22 - $19.09 $899,131 - $1.3 Million	68,013 Added 10.21%	734,366 $10.2 Million
Q1 2021 May 14, 2021	BUY	$16.68 - $23.97 $1.11 Million - $1.6 Million	66,836 Added 11.15%	666,353 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $8.87 Million - $12.7 Million	599,517 New	599,517 $10.6 Million

Others Institutions Holding KNSA

# of Institutions

165

Shares Held

40.6M

Call Options Held

186K

Put Options Held

157K

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $644M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History